Parker Moss

Cancer Research UK is the worlds leading cancer charity dedicated to saving lives through research, influence and information. Nearly one in two of us will get cancer in our lifetime, but we’re finding new ways to outsmart it, so that more people can live longer, better lives free from the fear of cancer.  We carry out scientific research to help prevent, diagnose and treat cancer and our groundbreaking work, funded almost entirely by the general public, will ensure that millions more people survive. Together we are beating cancer. Registered charity No. 1089464.

Genomics England works with the NHS to bring forward the use of genomic healthcare and research in Britain to help people live longer, healthier lives. Genomics is a ground-breaking area of medicine that uses our unique genetic code to help diagnose, treat and prevent illnesses. Thanks to advanced technology, scientists can now compare many people’s genetic code to make new discoveries that continually improve genomic healthcare. In 2013, Genomics England and the NHS launched the 100,000 Genomes Project, demonstrating how genomics insights can help doctors across the NHS, and building a foundation for the future by assembling a unique dataset. Genomics England is now supporting the NHS to deliver genomic testing for patients as part of routine healthcare, and providing the health data and technology that researchers need to make new discoveries and create more effective, targeted medicines. We work with thousands of people – patients, doctors and scientists – to increase our collective knowledge and enable faster and deeper genomic research, to bring genomic healthcare to all who need it.

Cancer Research UK is the worlds leading cancer charity dedicated to saving lives through research, influence and information. Nearly one in two of us will get cancer in our lifetime, but we’re finding new ways to outsmart it, so that more people can live longer, better lives free from the fear of cancer.  We carry out scientific research to help prevent, diagnose and treat cancer and our groundbreaking work, funded almost entirely by the general public, will ensure that millions more people survive. Together we are beating cancer. Registered charity No. 1089464.

Eight Roads Ventures is a global venture capital firm backed by Fidelity that helps entrepreneurs scale. We partner with game-changing technology and healthcare companies with a presence in Europe, India, China, Japan and the US. Our global platform has 50+ years of venture investing experience, $11 billion in AUM, over 600 portfolio companies and 60+ IPOs.

Bernstein is widely recognized as Wall Streets premier sell-side research and brokerage firm, with a global equity trading platform that spans the U.S., Europe, and Asia. Our firm was founded in the U.S. in 1967 and in the U.K. in 1999. Our research and trading capabilities are sought out by leading investment managers around the world, and we are annually ranked at the top of our industry by acknowledged arbiters. In independent surveys of major institutional clients, Bernsteins research is ranked #1 for overall quality, industry knowledge, most trusted, best detailed financial analysis, major company studies, most useful valuation frameworks and best original research. In Institutional Investor’s latest annual client survey, the leading survey by which research analysts in our industry are evaluated, over 90% of our U.S. analysts and the majority of our European Analysts were recognized as among the best in their respective fields – more than any other firm in our industry. We began operations in Hong Kong in 2010, and now cover a range of sectors across Asia. Our European research team is also home to Extels #1-ranked analyst across Europe. In April 2019 we acquired Autonomous Research, a highly regarded global financial services independent research firm. The combination of Bernstein and Autonomous solidifies our standing as the largest global independent research firm. Research has always been Bernsteins calling card. The brand is defined by our renowned Blackbooks, known for their unbiased, in-depth company and industry forecasts. We have a community of Research Analysts who are acknowledged thought leaders that typically have many years of experience in the industries they cover. Our reputation is for the very highest caliber of independent and disciplined investment and industry analysis. We are a wholly-owned subsidiary of our buy-side parent, AB.